FDA Adverse Event Injury Summary report: N

GORE® TAG® THORACIC ENDOPROSTHESIS

MDR report key: 5624395 · Received May 2, 2016

Report

Report Number
2017233-2016-00424
Event Type
Injury
Date Received
May 2, 2016
Date of Event
July 28, 2010
Report Date
April 4, 2016
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P040043
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

ON (B)(6) 2010, THIS PATIENT UNDERWENT ENDOVASCULAR REPAIR OF AN ULCER-LIKE PROJECTION (ULP) IN THE THORACIC AORTA USING TWO GORE TAG THORACIC ENDOPROSTHESES (TGT3420/7842908 AND TGT3410/06821962). TGT3410 WAS IMPLANTED PROXIMALLY AND TGT3420 WAS DEPLOYED DISTALLY. THE PATIENT TOLERATED THE PROCEDURE. ON (B)(6) 2010, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL. ON (B)(6) 2010, FOLLOW-UP IMAGING REVEALED A MINOR PROXIMAL TYPE I ENDOLEAK. A WAIT-AND-WATCH APPROACH WAS TAKEN TO THE ENDOLEAK. ON (B)(6) 2010, IN ONE-MONTH FOLLOW-UP STUDY, THE PROXIMAL TYPE I ENDOLEAK REMAINED. ANEURYSM DIAMETER WAS 45 MM. ON (B)(6) 2011, IN SIX-MONTH FOLLOW-UP STUDY, THE PROXIMAL TYPE I ENDOLEAK WAS STILL PRESENT. ANEURYSM DIAMETER WAS 43 MM. ON (B)(6) 2011, A PSEUDOANEURYSM WAS REVEALED AT THE DISTAL EDGE OF THE TGT3420. THE PHYSICIAN COMMENTED THAT THE PSEUDOANEURYSM MAY HAVE BEEN CAUSED BY THE TAG DEVICE. THE PATIENT WAS IMPLANTED WITH ADDITIONAL ENDOPROSTHESES (MANUFACTURER UNKNOWN) TO REPAIR THE PSEUDOANEURYSM. ON (B)(6) 2011, IN ONE-YEAR FOLLOW-UP STUDY, THE PERSISTENT PROXIMAL TYPE I ENDOLEAK STILL REMAINED. THE ENDOLEAK WAS MONITORED. ANEURYSM DIAMETER WAS 41 MM. ON (B)(6) 2012, IN TWO-YEAR FOLLOW-UP STUDY, ANEURYSM DIAMETER WAS 44 MM. ENDOLEAKS COULD NOT BE IDENTIFIED. IN TWO FOLLOW-UP STUDIES PERFORMED, ENDOLEAKS COULD NOT BE IDENTIFIED. ANEURYSM DIAMETER WAS 43 MM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
278668 GORE® TAG® THORACIC ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES 7842908

Patients

Seq Age Sex Outcome Treatment
1 83 YR Hospitalization| R (B)(6) 2010: TGT3410/06821962